143 related articles for article (PubMed ID: 36362375)
1. Identification of Hypoxia-Related Prognostic Signature and Competing Endogenous RNA Regulatory Axes in Hepatocellular Carcinoma.
Tang Y; Zhang H; Chen L; Zhang T; Xu N; Huang Z
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362375
[TBL] [Abstract][Full Text] [Related]
2. Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma.
Zhou X; Dou M; Liu Z; Jiao D; Li Z; Chen J; Li J; Yao Y; Li L; Li Y; Han X
J Immunol Res; 2021; 2021():5518908. PubMed ID: 34426790
[TBL] [Abstract][Full Text] [Related]
3. Construction of a New Immune-Related Competing Endogenous RNA Network with Prognostic Value in Lung Adenocarcinoma.
Liu L; Li J; Fan C; Wen M; Li C; Sun W; Wang W
Mol Biotechnol; 2024 Feb; 66(2):300-310. PubMed ID: 37118319
[TBL] [Abstract][Full Text] [Related]
4. Lnc-AIFM2-1 promotes HBV immune escape by acting as a ceRNA for miR-330-3p to regulate CD244 expression.
Xie C; Wang S; Zhang H; Zhu Y; Jiang P; Shi S; Si Y; Chen J
Front Immunol; 2023; 14():1121795. PubMed ID: 36845111
[TBL] [Abstract][Full Text] [Related]
5. A prognostic four-gene signature and a therapeutic strategy for hepatocellular carcinoma: Construction and analysis of a circRNA-mediated competing endogenous RNA network.
Zhang HY; Zhu JJ; Liu ZM; Zhang YX; Chen JJ; Chen KD
Hepatobiliary Pancreat Dis Int; 2024 Jun; 23(3):272-287. PubMed ID: 37407412
[TBL] [Abstract][Full Text] [Related]
6. Functional lncRNA-miRNA-mRNA Networks in Response to Baicalein Treatment in Hepatocellular Carcinoma.
Zhao X; Tang D; Chen X; Chen S; Wang C
Biomed Res Int; 2021; 2021():8844261. PubMed ID: 33511213
[TBL] [Abstract][Full Text] [Related]
7. Analysis of ceRNA Network and Identification of Potential Treatment Target and Biomarkers of Endothelial Cell Injury in Sepsis.
Li Y; Fu Q; Fang J; Xu Z; Zhang C; Tan L; Liao X; Wu Y
Genet Test Mol Biomarkers; 2024 Apr; 28(4):133-143. PubMed ID: 38501698
[No Abstract] [Full Text] [Related]
8. Long Noncoding RNA
Mu W; Guo L; Liu Y; Yang H; Ning S; Lv G
Front Oncol; 2021; 11():784067. PubMed ID: 34917510
[TBL] [Abstract][Full Text] [Related]
9. Ferroptosis-related lncRNA NRAV affects the prognosis of hepatocellular carcinoma via the miR-375-3P/SLC7A11 axis.
Zong K; Lin C; Luo K; Deng Y; Wang H; Hu J; Chen S; Li R
BMC Cancer; 2024 Apr; 24(1):496. PubMed ID: 38637761
[TBL] [Abstract][Full Text] [Related]
10. Construction of a TP53 mutation-associated ceRNA network as prognostic biomarkers in hepatocellular carcinoma.
Wang D; Shi W; Qiu C
Heliyon; 2024 May; 10(9):e30066. PubMed ID: 38737272
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of ceRNA network related to lincRNA in glioblastoma and prediction of clinical prognosis.
Liu G; Liu D; Huang J; Li J; Wang C; Liu G; Ge S; Gong H
BMC Cancer; 2021 Jan; 21(1):98. PubMed ID: 33499813
[TBL] [Abstract][Full Text] [Related]
12. A hypoxia-glycolysis-lactate-related gene signature for prognosis prediction in hepatocellular carcinoma.
Qin X; Sun H; Hu S; Pan Y; Wang S
BMC Med Genomics; 2024 Apr; 17(1):88. PubMed ID: 38627714
[TBL] [Abstract][Full Text] [Related]
13. Machine Learning Gene Signature to Metastatic ccRCC Based on ceRNA Network.
Farias E; Terrematte P; Stransky B
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673800
[TBL] [Abstract][Full Text] [Related]
14. Identification of key molecules in the formation of portal vein tumor thrombus in hepatocellular carcinoma based on single cell transcriptomics and
Zhang M; Su C; Liu X; Hu S; Yan X
Transl Cancer Res; 2024 Apr; 13(4):1737-1761. PubMed ID: 38737676
[TBL] [Abstract][Full Text] [Related]
15. How CLSPN could demystify its prognostic value and potential molecular mechanism for hepatocellular carcinoma: A crosstalk study.
Shi Y; Wang Y; Niu K; Zhang W; Lv Q; Zhang Y
Comput Biol Med; 2024 Apr; 172():108260. PubMed ID: 38492457
[TBL] [Abstract][Full Text] [Related]
16. A prognostic model composed of four long noncoding RNAs predicts the overall survival of Asian patients with hepatocellular carcinoma.
Gu X; Li H; Sha L; Zhao W
Cancer Med; 2020 Aug; 9(16):5719-5730. PubMed ID: 32946170
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic, prognostic, drug sensitivity and ceRNA internet of
Li X; Pan Y; Feng S; Xing W; Lin B; Li W; Li M; Zhu M
Transl Cancer Res; 2024 Feb; 13(2):594-612. PubMed ID: 38482448
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of key miRNAs and a microRNA-mRNA regulatory network associated with liver cancer.
Tang J; Li S; Zhou Z; Chang W; Wang Y; Mei J; Zhou S
Cell Cycle; 2024 Feb; 23(4):353-368. PubMed ID: 38547309
[TBL] [Abstract][Full Text] [Related]
19. A Hypoxia-Related miRNA-mRNA Signature for Predicting the Response and Prognosis of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma.
Zong S; Huang G; Pan B; Zhao S; Ling C; Cheng B
J Hepatocell Carcinoma; 2024; 11():525-542. PubMed ID: 38496249
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of hepatocellular carcinoma progression: MicroRNAs as therapeutic, diagnostic and prognostic factors.
Hashemi M; Daneii P; Asadalizadeh M; Tabari K; Matinahmadi A; Bidoki SS; Motlagh YSM; Jafari AM; Ghorbani A; Dehghanpour A; Nabavi N; Tan SC; Rashidi M; Taheriazam A; Entezari M; Goharrizi MASB
Int J Biochem Cell Biol; 2024 May; 170():106566. PubMed ID: 38513802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
